Eli Lilly (LLY) trades near $1,150, up about 52% over the past year, and is now worth more than a trillion dollars. At that ...

Berenburg upgrades Eli Lilly stock to Buy from Hold, citing growth prospects fueled by its weight-loss drugs.

Eli Lilly has turned into one of the market’s biggest healthcare stories, with the share price at US$1,136.11 and a very ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. An illustrative graphic projects Eli Lilly's (LLY) stock ...

Eli Lilly (LLY-0.65%) stock has soared in recent years. Part of the reason may be due to the company's broad portfolio of drugs across treatment areas, from neuroscience to cancer and dermatology. But ...

Eli Lilly shed billions in market value over the past month while its underlying business kept breaking records, and now one major Wall Street firm sees a setup that almost never appears in a stock ...

Eli Lilly has split four times since 1986, with the latest split implemented in October 1997. Today, the company, surging in ...

Eli Lilly (LLY) stock gains 2% after Citigroup sets a Street-high $1,600 price target and Berenberg upgrades to Buy, citing ...

Eli Lilly (LLY) stock looks attractive vs. overextended semiconductors, with strong Q2 growth and reasonable PEG. See here for more details.

According to Aktiencheck on September 18, 2026, Berenberg upgraded Eli Lilly and Co. from Hold to Buy and raised its price ...

Shares recently traded at $1,280 each, so a split wouldn't be surprising.